TNDM - TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline | Benzinga
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) ("Tandem Diabetes Care" or the "Company") a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on behalf of investors who acquired securities within the class period. Investors are encouraged to review the following information.
Lead Plaintiff Deadline: November 7, 2023
Class Period: August 3, 2022 and November 2, 2022
Docket #: 23-CV-01657
If you would like to review the complaint and join the class action please follow the link below for more information:
https://www.johnsonfistel.com/investigations/tandem-diabetes-care-class-action
There is no cost or obligation to you.
Complaint Allegations: The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, ...